Skip to main content
. Author manuscript; available in PMC: 2018 Mar 29.
Published in final edited form as: J Med Chem. 1994 Nov 11;37(23):4020–4030. doi: 10.1021/jm00049a021

Table 3.

Characterization of Xanthine Derivatives

compd methoda % yieldb mp (°C) MSc formula analysis
4 A 75 165.5–169 EI: 164 (M+) C13H20N4O2 C, H, N
7 A 68 137–140 EI: 298 (M+) C16H18N4O2 C, H, N
11 B 60 170–172 FAB: 426 (M+ + 1) C11H14N4O4 f
12ad C 57 192–194 FAB: 454 (M+ + 1) C23H27N5O5 C, H, Nf
12b C 66e 159–160 FAB: 440 (M+ + 1) C22H25N5O5·0.5DMF C, H, Nf
14 B 32 260–263 335, 352 C16H22N4O4·0.5DMF C, H, N
15 C 91 129–130 363 C17H24N4O4 C, H, N
16 C 66 225–230 349 C17H24N4O4·0.5DMF C, H, N
17 B 45 229–230 337 (M+ + 1), 354 (M+ + 18) C16H24N4O4 C, H, N
18 B 39 189–191 348, 365 C17H26N4O4 C, H, N
19 B 19 225 dec 365, 382 C18J28N4O4·0.15NH4OH C, H, N
20 B 56 239–240 267 (M+ + 1) C11H14N4O4 C, H, N
21 B 48 245–247 dec 283 (M+ + 1), 300 (M+ + 18) C11H14N4O3S1·1.18H2O C, H, N
30 D 57 325–330 dec 415 (M+ + 1) C21H26N4O5·0.5NH4OH C, H, N
33 D 78 172–173 C40H43N7O9·1.5H2O C, H, N
34 D 100 215–220 dec 544 C25H33N7O7·1.5H2O C, H, N
35 D 70 204–207 dec FAB: 644 (M+ + 1) C23H33N8O10 f
a

Methods: (A) synthesis as in Scheme 1; (B) synthesis as in Scheme 2; (C) refer to text; (D) refer to Scheme 3.

b

Percent yield calculated from 1,3-dialkyl-6-amino-5-nitrosouracil.

c

CI, unless noted.

d

Methyl ester of compound 12b.

e

Saponification step.

f

High-resolution mass, measured (ppm from calculated), in FAB mode: 11, 426.1778 (+0.1); 12a, 454.2091 (+0.2); 12b, 440.1944 (+2.2); 35, 644.2686 (+0.8).